This protein can interact with p-PDK1 and act as a tumor suppressor by preventing AKT Thr-308 phosphorylation and inhibiting the malignant phenotype and glioma progression by decreasing the RTK/PI3K/AKT signaling pathway (111, 112). The gene discussed is AKT1; the disease is neoplasm.